← FDA Drug Approvals (Drugs@FDA)

OLOPATADINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 2015-02-02

Drug application

FDA Application #
ANDA203416
Application type
Abbreviated New Drug Application (Generic)
Brand name
OLOPATADINE HYDROCHLORIDE
Generic name
Olopatadine Hydrochloride
Active ingredients
OLOPATADINE HYDROCHLORIDE
Dosage form
SOLUTION
Route
OPHTHALMIC
Marketing status
None (Tentative Approval)
Sponsor
WATSON LABS
First approval
2015-02-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown